ArticlePsycho-oncology2026
Mental Health and Survival in Medicare Beneficiaries With Lung and Head and Neck Cancer.
Article in Psycho-oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMental health (MH) conditions can significantly influence cancer outcomes, yet associations with survival and potential impacts of MH care utilization remain underexplored.
aimsExamine associations between (1) MH diagnoses and (2) MH utilization and survival among Medicare beneficiaries with lung or head and neck (HN) cancers.
methodsPatients diagnosed with lung or HN cancers between 2004 and 2018 were stratified by MH diagnosis status in the two years prior to cancer diagnosis. We examined factors associated with MH diagnosis and MH services and evaluated overall and cancer specific survival analyses using Kaplan-Meier survival analyses and multivariable Cox regressions.
results19% of patients with a lung cancer diagnosis (n = 333,875) and 15% of HN patients (n = 39,253) received a MH diagnosis within two years before cancer diagnosis. Kaplan-Meier survival analysis indicated significantly worse survival among patients with a MH diagnosis and higher rates of survival among those receiving MH services. Among individuals with a MH diagnosis, the mortality hazard for individuals that received MH services was lower compared to those who did not receive MH services, in both HN and Lung cancer.
conclusionsMH conditions were common in people with lung and HN cancers and associated with worse overall and cancer-specific survival for head and neck cancer. Among those with MH diagnoses, receipt of MH services was associated with lower hazard of death, highlighting the need for early identification of this at-risk population and integration of MH care into oncology care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.